A phase 2 study of durvalumab plus DOS (docetaxel, oxaliplatin, S-1) neoadjuvant chemotherapy followed by surgery and adjuvant durvalumab plus S-1 chemotherapy in patients with resectable locally advanced gastric cancer: An interim efficacy report.

被引：0
|
作者：
Kim, Hyung-Don
Ryu, Min-Hee
Park, Young Soo
Lee, Jong Seok
Kang, Yoon-Koo
机构：
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea
[2] Asan Med Ctr, Dept Pathol, Seoul, South Korea
[3] Asan Med Ctr, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
408
引用
收藏
页码：408 / 408
页数：1
相关论文
共 50 条
  • [21] Neoadjuvant docetaxel, oxaliplatin and S-1 (DOS) combination chemotherapy for patients with resectable adenocarcinoma of esophagogastric junction
    Saito, Takuro
    Kurokawa, Yukinori
    Takahashi, Tsuyoshi
    Yamamoto, Kazuyoshi
    Yamashita, Kotaro
    Tanaka, Koji
    Makino, Tomoki
    Nakajima, Kiyokazu
    Eguchi, Hidetoshi
    Doki, Yuichiro
    GASTRIC CANCER, 2022, 25 (05) : 966 - 972
  • [22] A phase I study of docetaxel/oxaliplatin/S-1 (DOS) combination neoadjuvant chemotherapy for patients with locally advanced adenocarcinoma of the esophagogastric junction
    Kei Hosoda
    Mizutomo Azuma
    Chikatoshi Katada
    Kenji Ishido
    Masahiro Niihara
    Hideki Ushiku
    Mikiko Sakuraya
    Marie Washio
    Takuya Wada
    Akinori Watanabe
    Hiroki Harada
    Satoshi Tanabe
    Wasaburo Koizumi
    Keishi Yamashita
    Naoki Hiki
    International Journal of Clinical Oncology, 2020, 25 : 1090 - 1097
  • [23] A phase I study of docetaxel/oxaliplatin/S-1 (DOS) combination neoadjuvant chemotherapy for patients with locally advanced adenocarcinoma of the esophagogastric junction
    Hosoda, Kei
    Azuma, Mizutomo
    Katada, Chikatoshi
    Ishido, Kenji
    Niihara, Masahiro
    Ushiku, Hideki
    Sakuraya, Mikiko
    Washio, Marie
    Wada, Takuya
    Watanabe, Akinori
    Harada, Hiroki
    Tanabe, Satoshi
    Koizumi, Wasaburo
    Yamashita, Keishi
    Hiki, Naoki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (06) : 1090 - 1097
  • [24] A phase I study of docetaxel/oxaliplatin/S-1 (DOS) combination neoadjuvant chemotherapy for patients with locally advanced adenocarcinoma of the esophagogastric junction
    Hosoda, K.
    Azuma, M.
    Katada, C.
    Ishido, K.
    Niihara, M.
    Ushiku, H.
    Sakuraya, M.
    Washio, M.
    Wada, T.
    Watanabe, A.
    Harada, H.
    Tanabe, S.
    Koizumi, W.
    Yamashita, K.
    Hiki, N.
    Watanabe, M.
    ANNALS OF ONCOLOGY, 2019, 30
  • [25] S-1 plus oxaliplatin compared with fluorouracil/leucovorin/oxaliplatin as neoadjuvant chemotherapy for locally advanced gastric carcinoma.
    Yu, Jiren
    Wu, Yijun
    Gao, Yuan
    Shen, Qianyun
    Zhang, Qing
    Liu, Xiaosun
    Zhu, Kankai
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [26] Dose-finding study on adjuvant chemotherapy with S-1 plus oxaliplatin for gastric cancer
    Yang, Lin
    Yang, Yi
    Qin, Qiong
    Zhou, Aiping
    Zhao, Jianjun
    Wang, Jinwan
    Shu, Chang
    Yuan, Xinghua
    Hu, Songnian
    MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (01) : 93 - 98
  • [27] Perioperative chemotherapy with docetaxel plus oxaliplatin and S-1 (DOS) versus oxaliplatin plus S-1 (SOX) for locally advanced gastric or gastro-esophageal junction adenocarcinoma (MATCH): An open-label, randomized, phase 2 study.
    Zhang, Wen
    Du, Chun-Xia
    Jiang, Zhichao
    Sun, Yongkun
    Xie, Yibin
    Zhong, Yuxin
    Zhu, Yuelu
    Jiang, Liming
    Dou, Lizhou
    Xue, Qi
    Shao, Kang
    Gao, Shugeng
    Wang, Chengfeng
    Zhao, Dongbing
    Tian, Yantao
    Zhou, Ai-Ping
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [28] Phase I study of docetaxel, oxaliplatin and S-1 (DOS) for patients with advanced gastric cancer
    Zang, D.
    Yang, D.
    Lee, H.
    Lee, B.
    Hwang, S.
    Kim, H.
    Song, H.
    Jung, J.
    Kim, J.
    Kwon, J.
    EJC SUPPLEMENTS, 2007, 5 (04): : 276 - 276
  • [29] Phase II study of docetaxel, oxaliplatin and S-1 (DOS) for patients with advanced gastric cancer
    Zang, D.
    Kang, Y.
    Ryu, B.
    Ryu, M.
    Lee, S.
    Kim, H.
    Kim, J.
    Jung, J.
    Kwon, J.
    Kim, H.
    EJC SUPPLEMENTS, 2009, 7 (02): : 375 - 375
  • [30] A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced gastric cancer
    Ohnuma, H.
    Sato, Y.
    Takayama, T.
    Sagawa, T.
    Hirakawa, M.
    Harada, K.
    Nobuoka, T.
    Hirata, K.
    Sato, Y.
    Takahashi, Y.
    Katsuki, S.
    Takahashi, S.
    Hirayama, M.
    Takahashi, M.
    Maeda, M.
    Sato, T.
    Miyanishi, K.
    Kobune, M.
    Takimoto, R.
    Kato, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345